SERPINE1 and metabolic syndrome: A dose-response relationship has been found between PAI-1 and such metabolism syndrome-related factors as obesity, hypertriglyceridemia, low high-density lipoprotein hyperlipidemia, hyperglycemia, hyperinsulinemia, and physical labor deficiency [21].